NM_004387.4(NKX2-5):c.827C>G (p.Ala276Gly) AND Cardiovascular phenotype

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Jan 26, 2019
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV002429460.1

Allele description [Variation Report for NM_004387.4(NKX2-5):c.827C>G (p.Ala276Gly)]

NM_004387.4(NKX2-5):c.827C>G (p.Ala276Gly)

Gene:

NKX2-5:NK2 homeobox 5 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

5q35.1

Genomic location:

Preferred name:

NM_004387.4(NKX2-5):c.827C>G (p.Ala276Gly)

HGVS:

NC_000005.10:g.173232717G>C
NG_013340.1:g.7596C>G
NM_001166175.2:c.*780C>G
NM_001166176.2:c.*626C>G
NM_004387.4:c.827C>GMANE SELECT
NP_004378.1:p.Ala276Gly
LRG_671t1:c.827C>G
LRG_671:g.7596C>G
LRG_671p1:p.Ala276Gly
NC_000005.9:g.172659720G>C
NM_004387.3:c.827C>G

Protein change:

A276G

Links:

dbSNP: rs751564052

NCBI 1000 Genomes Browser:

rs751564052

Molecular consequence:

NM_001166175.2:c.*780C>G - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
NM_001166176.2:c.*626C>G - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
NM_004387.4:c.827C>G - missense variant - [Sequence Ontology: SO:0001583]

Observations:

Condition(s)

Name:: Cardiovascular phenotype
Identifiers:: MedGen: CN230736

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV002680165	Ambry Genetics	criteria provided, single submitter (Ambry General Variant Classification Scheme_2022)	Uncertain significance (Jan 26, 2019)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV002680165

Ambry Genetics

criteria provided, single submitter

(Ambry General Variant Classification Scheme_2022)

Uncertain significance
(Jan 26, 2019)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	1	not provided	not provided	1	not provided	clinical testing

Details of each submission

From Ambry Genetics, SCV002680165.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	1	not provided	not provided	clinical testing	not provided

Description

The p.A276G variant (also known as c.827C>G), located in coding exon 2 of the NKX2-5 gene, results from a C to G substitution at nucleotide position 827. The alanine at codon 276 is replaced by glycine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species, and glycine is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	1	not provided	not provided		1	not provided	not provided	not provided

Last Updated: Mar 16, 2024

ClinVar

Relating variation to medicine